US Patent Issued to Vertex Pharmaceuticals on Dec. 30 for "Formulations of 3-(6-(1-(2,2-difluorobenzo[d[1,3dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid" (Massachusetts Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,231, issued on Dec. 30, was assigned to Vertex Pharmaceuticals Inc. (Boston).

"Formulations of 3-(6-(1-(2,2-difluorobenzo[d[1,3dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid" was invented by Marinus Jacobus Verwijs (Framingham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a disintegrant, a surfactant, a binder, and a lubricant, the composition being suitable for oral administration to a patient in need there...